SecBot SecBot
Insider Cluster (4 insiders) ·Filed Apr 9, 2026

DNA

Ginkgo Bioworks Holdings, Inc.
BEARISH
Impact 6/10
Horizondays Processed7mo ago
Insider cluster: 4 insiders, $2.5M total
Actionable Insight ▼ Bearish

The scale of insider selling (~0.5% of market cap) by multiple executives and a major shareholder raises concerns about confidence in near-term prospects. Monitor for follow-up filings or downward revisions in guidance that could confirm negative sentiment.

DirectionBearish
Confidencehigh
Horizondays

How the stock moved after the report

BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$6.43
T+0 close · Apr 8, 2026 · via day close
Latest settled
+57.23%
T+60 · $10.11
Vs SPY
+46.45%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 9 $6.43entry
  2. T+1 · 7mo ago +0.31%α +0.37% · $6.45
  3. T+5 · 7mo ago +23.64%α +20.45% · $7.95
  4. T+20 · 6mo ago +56.77%α +49.20% · $10.08
  5. T+60 · 4mo ago +57.23%α +46.45% · $10.11
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Four insiders, including executives and a 10% owner, sold $2.52M in shares over a 7-day period, with open-market sales averaging $6.41–$6.43 per share. The activity follows a prior cluster involving derivative exercises and a small open-market sale by the same insider.

Key Financial Metrics

Direction
selling
Total Value
$2.5M
Insiders
4

Key Facts

  • Insider cluster involves $2.52M in total open-market sales over 7 days
  • Sellers include executives Jason R. Kelly and Reshma P. Shetty, plus 10% owner Barry Canton
  • Average sale price: ~$6.41–$6.43, totaling 392.2K shares sold
  • All transactions are open-market sales (S code), not non-cash events
  • Total value represents ~0.51% of $497M market cap, modest but notable

Financial Impact

$2.52 million in open-market sales by insiders

insider sentimentmarket confidenceshare supply

Risk Factors

  • Insider selling may signal lack of confidence in current valuation or upcoming results
  • Potential for increased selling pressure if other holders follow suit

Market Snapshot

Exchange
OTC
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-DNA-1776718985742

Track record

7 reports on DNA

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 5, 202611d ago 8-K Neutral 5/10 Entry $11.29 Now $8.50 −24.71% settles Feb 4
  2. Oct 29, 202618d ago 8-K Neutral 2/10 Entry $11.21 Now $8.50 −24.17% settles Jan 28
  3. Oct 21, 202626d ago Insider Cluster Neutral 2/10 Entry $9.71 Now $8.50 −12.46% settles Jan 20
  4. Oct 19, 202628d ago 144 Neutral 2/10 Entry $10.07 Now $8.50 −15.59% settles Jan 14
  5. Sep 15, 20268w ago 144 Neutral 2/10 Entry $6.99 Now $8.50 +21.60% settles Dec 9
  6. Apr 9, 202631w ago Insider Cluster Bearish 6/10 Viewing Entry $6.43 to $10.11 Now $8.50 −32.19% ▼ −57.23% −46.45% vs SPY
  7. Apr 9, 202631w ago Insider Cluster Bearish 6/10 Entry $6.43 to $10.11 Now $8.50 −32.19% ▼ −57.23% −46.45% vs SPY
Showing 7 of 7

US Market Status

Market Closed · Opens in 6h 15m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 20, 2026